Urszula Wojtyra

2024 Highlights In Canadian Life Sciences IP And Regulatory Law

Agile Licensing Amendments Registered

PMPRB Releases New Draft Guidelines For Comment

PM(NOC) Regulations: Seven-year Anniversary Of Major Amendments

Manitoba Last Province To Introduce Biosimilars Initiative, While Ontario Adds Four Drugs To Its Biosimilar Policy

2024 Mid-Year Highlights In Canadian Life Sciences IP And Regulatory Law

Update On Biosimilars In Canada – March 2024

Federal Court Finds PMPRB Reasonably Concluded Galderma's Patent Claiming 0.3% Adapalene "Pertained To" 0.1% Adapalene DIFFERIN

2023 Highlights in Canadian Life Sciences IP and Regulatory Law

Government Of Canada Announces Creation Of Canadian Drug Agency